A detailed history of Jennison Associates LLC transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Jennison Associates LLC holds 8,926 shares of LNTH stock, worth $797,002. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,926
Holding current value
$797,002
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$77.7 - $123.62 $693,550 - $1.1 Million
8,926 New
8,926 $979,000
Q2 2023

Aug 03, 2023

SELL
$82.41 - $99.65 $71,284 - $86,197
-865 Reduced 10.66%
7,246 $608,000
Q1 2023

Apr 26, 2023

BUY
$47.76 - $82.86 $387,381 - $672,077
8,111 New
8,111 $669,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.14B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Jennison Associates LLC Portfolio

Follow Jennison Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.